Access to COVID-19 Vaccines From Oxford/AstraZeneca, Johnson & Johnson, Moderna & Pfizer/BioNTech in 17 Middle-Income Countries

Posted on

by

Access to COVID-19 Vaccines From Oxford/AstraZeneca, Johnson and Johnson, Moderna and Pfizer/BioNTech in 17 Middle-Income Countries

The report assesses and provides detailed information on the availability and affordability of COVID-19 vaccines from Oxford/AstraZeneca, Johnson and Johnson (J & J), Moderna, and Pfizer/BioNTech, covering 17 MICs where our Make Medicines Affordable (MMA) campaign partners work –  Argentina, Armenia, Belarus, Brazil, El Salvador, Georgia, Guatemala, Honduras, India, Kazakhstan, Kyrgyzstan, Moldova, Morocco, Russia, Thailand, Ukraine and Vietnam. The information they gathered covers vaccine supply, delivery, donations, pricing and technology transfer during the period between 1 January 2021 and 19 January 2022.

This originally appeared on the Make Medicines Affordable website.